Metastatic Colorectal Cancers Withdrawn Phase 3 Trials for Regorafenib (DB08896)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01786538Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus FluoropyrimidinesTreatment